|
Volumn 2, Issue 2, 2014, Pages 167-176
|
CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTOKINE;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
ICOSLG PROTEIN, HUMAN;
INDUCIBLE T CELL COSTIMULATOR LIGAND;
IPILIMUMAB;
MONOCLONAL ANTIBODY;
PHOSPHATIDYLINOSITOL 3 KINASE;
SMALL INTERFERING RNA;
T BOX TRANSCRIPTION FACTOR;
T-BOX TRANSCRIPTION FACTOR TBX21;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
BIOSYNTHESIS;
C57BL MOUSE;
CANCER TRANSPLANTATION;
CARCINOMA, TRANSITIONAL CELL;
CD4+ T LYMPHOCYTE;
CLINICAL TRIAL;
DRUG EFFECTS;
GENETICS;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
KNOCKOUT MOUSE;
MELANOMA;
METABOLISM;
PATHOLOGY;
PROCEDURES;
SIGNAL TRANSDUCTION;
TH1 CELL;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CARCINOMA, TRANSITIONAL CELL;
CD4-POSITIVE T-LYMPHOCYTES;
CTLA-4 ANTIGEN;
CYTOKINES;
HUMANS;
IMMUNOTHERAPY;
INDUCIBLE T-CELL CO-STIMULATOR LIGAND;
MELANOMA;
MICE, INBRED C57BL;
MICE, KNOCKOUT;
NEOPLASM TRANSPLANTATION;
PHOSPHATIDYLINOSITOL 3-KINASES;
RNA, SMALL INTERFERING;
SIGNAL TRANSDUCTION;
T-BOX DOMAIN PROTEINS;
TH1 CELLS;
|
EID: 84996490571
PISSN: None
EISSN: 23266074
Source Type: Journal
DOI: 10.1158/2326-6066.CIR-13-0155 Document Type: Article |
Times cited : (40)
|
References (0)
|